STOPP/START criteria for potentially inappropriate medications/potential prescribing omissions in older people: origin and progress - PubMed (original) (raw)
Review
STOPP/START criteria for potentially inappropriate medications/potential prescribing omissions in older people: origin and progress
Denis O'Mahony. Expert Rev Clin Pharmacol. 2020 Jan.
Abstract
Introduction: STOPP (Screening Tool of Older Persons' Prescriptions) and START (Screening Tool to Alert to Right Treatment) are explicit criteria that facilitate medication review in multi-morbid older people in most clinical settings. This review examines the clinical trial evidence pertaining to STOPP/START criteria as an intervention.Areas covered: The literature was searched for registered clinical trials that used STOPP/START criteria as an intervention. In single-center trials, applying STOPP/START criteria improved medication appropriateness, reduced polypharmacy, reduced adverse drug reactions (ADRs), led to fewer falls, and lower medication costs. Two large-scale multi-center trials (SENATOR and OPERAM) examined the impact of computer-generated STOPP/START criteria on incident ADRs (SENATOR) and drug-related hospitalizations (OPERAM) in multi-morbid older people. Results of these trials will be publicized in 2020.Expert opinion: Applying STOPP/START criteria improves clinical outcomes in multi-morbid older people. Electronic deployment of STOPP/START criteria is a substantial technical challenge; however, recent clinical trials of software prototypes demonstrate feasibility. Even with well-functioning software for the application of STOPP/START criteria, the need remains for face-to-face interaction between attending clinicians and appropriately trained personnel (likely pharmacists) to explain and qualify specific STOPP/START recommendations in individual multi-morbid older patients. Such interaction is essential for the implementation of relevant STOPP/START recommendations.
Keywords: Adverse drug event; STOPP/START criteria; adverse drug reaction; elderly; hospital; inappropriate prescribing; nursing home; patient safety; prevention; primary care.
Similar articles
- STOPP/START criteria for potentially inappropriate medications/potential prescribing omissions in older people: uptake and clinical impact.
McGettigan S, Curtin D, O'Mahony D. McGettigan S, et al. Expert Rev Clin Pharmacol. 2023 Jul-Dec;16(12):1175-1185. doi: 10.1080/17512433.2023.2280219. Epub 2023 Dec 9. Expert Rev Clin Pharmacol. 2023. PMID: 37947757 Review. - Intervention protocol: OPtimising thERapy to prevent avoidable hospital Admission in the Multi-morbid elderly (OPERAM): a structured medication review with support of a computerised decision support system.
Crowley EK, Sallevelt BTGM, Huibers CJA, Murphy KD, Spruit M, Shen Z, Boland B, Spinewine A, Dalleur O, Moutzouri E, Löwe A, Feller M, Schwab N, Adam L, Wilting I, Knol W, Rodondi N, Byrne S, O'Mahony D. Crowley EK, et al. BMC Health Serv Res. 2020 Mar 17;20(1):220. doi: 10.1186/s12913-020-5056-3. BMC Health Serv Res. 2020. PMID: 32183810 Free PMC article. - Potentially Inappropriate Prescribing and Related Hospital Admissions in Geriatric Patients: A Comparative Analysis between the STOPP and START Criteria Versions 1 and 2.
Thevelin S, Mounaouar LE, Marien S, Boland B, Henrard S, Dalleur O. Thevelin S, et al. Drugs Aging. 2019 May;36(5):453-459. doi: 10.1007/s40266-018-00635-8. Drugs Aging. 2019. PMID: 30694444 - Evaluation of clarity of the STOPP/START criteria for clinical applicability in prescribing for older people: a quality appraisal study.
Sallevelt BTGM, Huibers CJA, Knol W, Puijenbroek EV, Egberts T, Wilting I. Sallevelt BTGM, et al. BMJ Open. 2020 Feb 18;10(2):e033721. doi: 10.1136/bmjopen-2019-033721. BMJ Open. 2020. PMID: 32075833 Free PMC article. - Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact.
Hill-Taylor B, Sketris I, Hayden J, Byrne S, O'Sullivan D, Christie R. Hill-Taylor B, et al. J Clin Pharm Ther. 2013 Oct;38(5):360-72. doi: 10.1111/jcpt.12059. Epub 2013 Apr 2. J Clin Pharm Ther. 2013. PMID: 23550814 Review.
Cited by
- Association between frailty and inappropriate prescribing in elderly patients admitted to an Acute Care of the Elderly Unit.
Zuleta M, Gozalo I, Sánchez-Arcilla M, Ibáñez J, Pérez-Bocanegra C, San-José A. Zuleta M, et al. Aging Med (Milton). 2024 Apr 16;7(5):553-558. doi: 10.1002/agm2.12304. eCollection 2024 Oct. Aging Med (Milton). 2024. PMID: 39507222 Free PMC article. - Under-Prescription of Drugs in the Elderly Population of Western Romania: An Analysis Based on STOPP/START Version 2 Criteria.
Baneu P, Prelipcean A, Buda VO, Jianu N, Tudor A, Andor M, Merlan C, Romanescu M, Suciu M, Buda S, Mateoc T, Gurgus D, Dehelean L. Baneu P, et al. J Clin Med. 2024 Oct 8;13(19):5970. doi: 10.3390/jcm13195970. J Clin Med. 2024. PMID: 39408034 Free PMC article. - Effect of polypharmacy and potentially inappropriate medications on physical functional decline among older adults with advanced cancer receiving systemic treatment.
Mohamed MR, Juba K, Awad H, Flannery M, Culakova E, Wells M, Cacciatore J, Jensen-Battaglia M, Mohile S, Ramsdale E. Mohamed MR, et al. Support Care Cancer. 2024 Sep 19;32(10):674. doi: 10.1007/s00520-024-08877-6. Support Care Cancer. 2024. PMID: 39294452 Clinical Trial. - Cooperation across healthcare service levels for medication reviews in older people with polypharmacy admitted to a municipal in-patient acute care unit (The COOP II Study): study protocol for a randomized controlled trial.
Santervas LR, Wyller TB, Skovlund E, Jensen JL, Fjeld KG, Hove LH, Ringstad IB, Nordberg LB, Mellingen KM, Kristoffersen ES, Romskaug R. Santervas LR, et al. Trials. 2024 Sep 13;25(1):612. doi: 10.1186/s13063-024-08442-w. Trials. 2024. PMID: 39272164 Free PMC article. - Potentially Inappropriate Medications Involved in Drug-Drug Interactions in a Polish Population over 80 Years Old: An Observational, Cross-Sectional Study.
Błeszyńska-Marunowska E, Jagiełło K, Wierucki Ł, Renke M, Grodzicki T, Kalarus Z, Zdrojewski T. Błeszyńska-Marunowska E, et al. Pharmaceuticals (Basel). 2024 Aug 5;17(8):1026. doi: 10.3390/ph17081026. Pharmaceuticals (Basel). 2024. PMID: 39204131 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical